NCT05755373View on ClinicalTrials.gov

A Multinational Survey-based Study to Understand the Real-world Awareness and Perceptions of Systemic inFLAMmation and rolE of hsCRP as a Biomarker in Patients With AtheroSclerotic CardioVascular Disease and Chronic Kidney Disease Among Cardiologists

CompletedOBSERVATIONAL
Enrollment

602

Participants

Timeline

Start Date

March 24, 2023

Primary Completion Date

May 15, 2023

Study Completion Date

May 15, 2023

Conditions
Atherosclerotic Cardiovascular Disease (ASCVD)Chronic Kidney Disease (CKD)
Interventions
OTHER

No treatment given

No treatment given

Trial Locations (1)

Unknown

Novo Nordisk Investigational Site, Bangalore

Sponsors

Lead Sponsor

Novo Nordisk A/S
All Listed Sponsors
lead

Novo Nordisk A/S

INDUSTRY

NCT05755373 - A Multinational Survey-based Study to Understand the Real-world Awareness and Perceptions of Systemic inFLAMmation and rolE of hsCRP as a Biomarker in Patients With AtheroSclerotic CardioVascular Disease and Chronic Kidney Disease Among Cardiologists | Biotech Hunter | Biotech Hunter